Cargando…
A high-throughput drug screening strategy against coronaviruses
The emergence and re-emergence of coronaviruses (CoV) continually cause circulating epidemics and pandemics worldwide, such as the on-going outbreak of the novel coronavirus SARS-CoV-2. The resultant disease, coronavirus disease 2019 (COVID-19), has rapidly developed into a worldwide pandemic, leadi...
Autores principales: | Liu, Jia, Li, Kang, Cheng, Lin, Shao, Jingjin, Yang, Shukun, Zhang, Wei, Zhou, Guangqian, de Vries, Antoine A.F., Yu, Zhiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832824/ https://www.ncbi.nlm.nih.gov/pubmed/33333250 http://dx.doi.org/10.1016/j.ijid.2020.12.033 |
Ejemplares similares
-
Assay development and high-throughput antiviral drug screening against Bluetongue virus
por: Li, Qianjun, et al.
Publicado: (2009) -
Reporter-Based Assays for High-Throughput Drug Screening against Mycobacterium abscessus
por: Gupta, Rashmi, et al.
Publicado: (2017) -
Strategies for drug repurposing against coronavirus targets
por: Smith, Poppy O., et al.
Publicado: (2021) -
Drug synergy discovery of tavaborole and aminoglycosides against Escherichia coli using high throughput screening
por: Liu, Shasha, et al.
Publicado: (2022) -
Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2016)